Yongsheng Zhu

Yongsheng Zhu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
YZYongsheng Zhu
Yongsheng Zhu
KWKejia Wang
Kejia Wang
TMTengfei Ma
Tengfei Ma
YJYuanyuan Ji
Yuanyuan Ji
YLYin Lou
Yin Lou
YWYunpeng Wang
Yunpeng Wang
The nucleus accumbens (NAc) is the most promising target for drug use disorder treatment. Deep brain stimulation (DBS) of NAc is effective for drug use disorder treatment. However, the mechanisms by which DBS produces its therapeutic effects remain enigmatic. Here, we define a behavioral cutoff criterion to distinguish depressive-like behaviors and non-depressive-like behaviors in mice after morphine withdrawal. We identified a basolateral amygdala (BLA) to NAc D1 medium spiny neuron (MSN) pathway that controls depressive-like behaviors after morphine withdrawal. Furthermore, the paraventricular nucleus of thalamus (PVT) to NAc D2 MSN pathway controls naloxone-induced acute withdrawal symptoms. Optogenetically induced long-term potentiation with κ-opioid receptor (KOR) antagonism enhanced BLA to NAc D1 MSN signaling and also altered the excitation/inhibition balance of NAc D2 MSN signaling. We also verified that a new 50 Hz DBS protocol reversed morphine withdrawal–evoked abnormal plasticity in NAc. Importantly, this refined DBS treatment effectively alleviated naloxone-induced withdrawal symptoms and depressive-like behaviors and prevented stress-induced reinstatement. Taken together, the results demonstrated that input- and cell type–specific synaptic plasticity underlies morphine withdrawal, which may lead to novel targets for the treatment of opioid use disorder.

2 June 2022 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
CDCuola Deji
Cuola Deji
PYPeng Yan
Peng Yan
YJYuanyuan Ji
Yuanyuan Ji
XYXinyue Yan
Xinyue Yan
YFYue Feng
Yue Feng
JLJianghua Lai
Jianghua Lai
Anxiety is one of the most common comorbid conditions reported in people with opioid dependence. The basolateral amygdala (BLA) and ventral hippocampus (vHip) are critical brain regions for fear and anxiety. The kappa opioid receptor (KOR) is present in the mesolimbic regions involved in emotions and addiction. However, the precise circuits and molecular basis underlying anxiety associated with chronic opioid use are poorly understood. Using a mouse model, we demonstrated that anxiety-like behaviors appeared in the first 2 weeks after morphine withdrawal. Furthermore, the BLA and vHip were activated in mice experiencing anxiety after morphine withdrawal (Mor-A). KORs in the BLA to vHip projections were significantly increased in the Mor-A group. Optogenetic/chemogenetic inhibition of BLA inputs ameliorated anxiety-like behaviors and facilitated conditioned place preference (CPP) extinction in Mor-A mice. Knockdown of the BLA to vHip circuit KOR alleviated the anxiety-like behaviors but did not affect CPP extinction or reinstatement. Furthermore, combined treatment of inhibition of the BLA to vHip circuit and KOR antagonists mitigated anxiety-like behaviors and prevented stress-induced CPP reinstatement after morphine withdrawal. These results revealed a previously unknown circuit associated with the emotional component of opioid withdrawal and indicated that restoration of synaptic deficits with KOR antagonists might be effective in the treatment of anxiety associated with morphine withdrawal.

1 January 2021 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
JZJianbo Zhang
Jianbo Zhang
CDCuola Deji
Cuola Deji
JFJingna Fan
Jingna Fan
LCLiao Chang
Liao Chang
XMXinyao Miao
Xinyao Miao
SLShengbin Li
Shengbin Li

10 November 2023 in Biological Psychiatry
Verified
Journal Article
Closed access
ZLZiyi Li
Ziyi Li
JLJiaxin Li
Jiaxin Li
YWYanxia Wei
Yanxia Wei
WZWanying Zou
Wanying Zou
OVOlivia Ewi Vidjro
Olivia Ewi Vidjro
TMTengfei Ma
Tengfei Ma

1 October 2024 in Advanced Science
Verified
Journal Article
Open access
RWRui Wang
Rui Wang
QLQing Liang
Qing Liang
QZQian Zhang
Qian Zhang
SZShuchao Zhao
Shuchao Zhao
YLYuxiang Lin
Yuxiang Lin
KWKejia Wang
Kejia Wang
Inflammation is highlighted as an initial factor that helps orchestrate liver reconstitution. However, the precise mechanisms controlling inflammation during liver reconstitution have not been fully elucidated. In this study, a clear immune response is demonstrated during hepatic reconstitution. Inhibition of the hepatic inflammatory response retards liver regeneration. During this process, Ccl2 is primarily produced by type 1 innate lymphoid cells (ILC1s), and ILC1‐derived Ccl2 recruits peripheral ILC1s and regulatory T cells (Tregs) to the liver. Deletion of Ccl2 or Tregs exacerbates hepatic injury and inflammatory cytokine release, accelerating liver proliferation and regeneration. The adoption of Tregs and IL‐10 injection reversed these effects on hepatocyte regenerative proliferation. Additionally, Treg‐derived IL‐10 can directly induce macrophage polarization from M1 to M2, which alleviated macrophage‐secreted IL‐6 and TNF‐α and balanced the intrahepatic inflammatory milieu during liver reconstitution. This study reveals the capacity of Tregs to modulate the intrahepatic inflammatory milieu and liver reconstitution through IL‐10‐mediated macrophage polarization, providing a potential opportunity to improve hepatic inflammation and maintain homeostasis.

11 October 2024 in Biological Psychiatry
Verified
Journal Article
Closed access
JLJiaxin Li
Jiaxin Li
YZYao Zhou
Yao Zhou
FYFangyuan Yin
Fangyuan Yin
YDYanfeng Du
Yanfeng Du
JXJiancheng Xu
Jiancheng Xu
TMTengfei Ma
Tengfei Ma